InvestSMART

Firebrick Pharma Limited (ASX: FRE) - Announcements

- Current share price for FRE : $0.028

ASX company news and announcements for Firebrick Pharma Limited (FRE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Firebrick Pharma Limited (FRE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Firebrick Pharma Limited (FRE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Firebrick Pharma Limited (FRE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 Update on Registration of Nasodine in the Philippines 12 Jan 2026 8:32AM $0.066 $0.028 fallen by 57.58%
$9 Results of Annual General Meeting 26 Nov 2025 11:42AM $0.065 $0.028 fallen by 56.92%
$9 Annual General Meeting Presentation 2025 26 Nov 2025 8:24AM $0.064 $0.028 fallen by 56.25%
$9 Notice of Change of Auditor 21 Nov 2025 8:46AM $0.065 $0.028 fallen by 56.92%
$9 Firebrick announces new product Nasodine Throat Spray 30 Oct 2025 9:52AM $0.064 $0.028 fallen by 56.25%
$9 Notice of AGM & Proxy Form & Letter to Shareholders 27 Oct 2025 10:58AM $0.063 $0.028 fallen by 55.56%
$9 September 2025 Quarterly Activity Report & Appendix 4C 23 Oct 2025 8:22AM $0.062 $0.028 fallen by 54.84%
$9 Becoming a substantial holder - Pharma Nutria NA Inc 17 Oct 2025 8:27AM $0.067 $0.028 fallen by 58.21%
$9 Cleansing Notice 17 Oct 2025 8:27AM $0.067 $0.028 fallen by 58.21%
$9 Application for quotation of securities - FRE 17 Oct 2025 8:27AM $0.067 $0.028 fallen by 58.21%
$9 Proposed issue of securities - FRE 16 Oct 2025 9:57AM $0.065 $0.028 fallen by 56.92%
$9 Firebrick Secures Investment from Philippines Partner 16 Oct 2025 9:53AM $0.065 $0.028 fallen by 56.92%
$9 Notification regarding unquoted securities - FRE 2 Oct 2025 9:07AM $0.066 $0.028 fallen by 57.58%
$9 Notice of AGM and Closing Date for Director Nominations 29 Sep 2025 8:28AM $0.063 $0.028 fallen by 55.56%
$9 Final Director's Interest Notice - Phyllis Gardner 12 Sep 2025 8:25AM $0.065 $0.028 fallen by 56.92%
$9 Passing of Director - Phyllis Gardner 11 Sep 2025 10:44AM $0.070 $0.028 fallen by 60%
$9 Cleansing Notice 11 Sep 2025 9:30AM $0.070 $0.028 fallen by 60%
$9 Application for quotation of securities - FRE 11 Sep 2025 9:30AM $0.070 $0.028 fallen by 60%
$9 Firebrick receives $250,000 R&D Tax Incentive 10 Sep 2025 8:26AM $0.071 $0.028 fallen by 60.56%
$9 Ceasing to be a substantial holder - Pharma Nutria NA Inc 2 Sep 2025 6:11PM $0.072 $0.028 fallen by 61.11%
$9 Change in substantial holding 1 Sep 2025 5:02PM $0.074 $0.028 fallen by 62.16%
$9 Change in substantial holding - Peter Molloy 29 Aug 2025 3:52PM $0.075 $0.028 fallen by 62.67%
$9 Change in substantial holding - Stephen Goodall 29 Aug 2025 3:52PM $0.075 $0.028 fallen by 62.67%
$9 Ceasing to be a substantial holder - Firebrick Pharma 29 Aug 2025 3:51PM $0.075 $0.028 fallen by 62.67%
$9 Cleansing Notice 29 Aug 2025 3:49PM $0.075 $0.028 fallen by 62.67%

76 - 100 of 523 results

Page 4 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.